Definitive Healthcare receives Nasdaq minimum bid price deficiency notice
Definitive Healthcare Corp. received notice from Nasdaq on June 18, 2026, that its common stock failed to meet the minimum bid price requirement of $1.00 per share over a 30 consecutive business day period ending June 17, 2026. The company has until December 15, 2026, to regain compliance; if the closing bid price reaches at least $1.00 for ten consecutive business days during that period, Nasdaq will confirm compliance and close the matter. If compliance is not achieved, the company may be eligible for an additional 180-calendar-day cure period if it meets other Nasdaq Capital Market listing standards, or face delisting.
Key facts
- Minimum bid price requirement: $1.00 per share
- Compliance period: 180 calendar days, until December 15, 2026
- Measurement period: 30 consecutive business days from May 6, 2026 to June 17, 2026
- Cure condition: closing bid price of at least $1.00 for minimum ten consecutive business days
- Potential additional compliance period: 180 calendar days, if other listing standards met
- Stock symbol: DH on Nasdaq Global Select Market
- Notice date: June 18, 2026
- Company considering reverse stock split as remedial option
Why it matters
The company faces potential delisting from Nasdaq if it cannot raise its bid price above $1.00 per share within six months, which would materially affect trading liquidity and investor access to the stock.
Share
Derived from 8-K filed 2026-06-24. Not investment advice. View the source filing on SEC.gov →